•
Dec 31, 2021

Mink Therapeutics Q4 2021 Earnings Report

Total Revenue
$222M
EPS
-$0.18
Previous year: -$0.0541
+233.0%
Cash and Equivalents
$38.9M
Free Cash Flow
-$1.7M
Total Assets
$40.2M

Mink Therapeutics

Mink Therapeutics